drugset / Trial / NCT01211028

Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine

NCT01211028 ↗

NaSingle-groupOpen-labelTreatment

Summary

The main purpose of this study is to evaluate the safety and feasibility of regenerative therapy with expanded adipose derived stroma/stem cells sue, administered intramuscularly in patients with critical leg ischemia.

Timeline

Start
2009-01
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Expanded autologous ASCs Cell therapy 100 cells Intramuscular